Recently, some studies showed that apoE deficiency appears to be a novel risk factor for pulmonary artery hypertension (PAH) and patients with PAH have reduced expression of apoE in their lungs [38,39]. The gene discussed is APOE; the disease is pulmonary arterial hypertension.